Mustang Bio (MBIO) Invested Capital (2019 - 2023)

Mustang Bio (MBIO) has reported Invested Capital for 5 consecutive years, with $31.0 million the latest figure, recorded in Q1 2023.

• In Q1 2023, Invested Capital rose 3728.61% year-over-year to $31.0 million; the TTM figure through Dec 2023 stood at $31.0 million (down 66.95% YoY), while the FY2022 annual figure was $31.0 million, up 4194.61% from the prior year.
• Invested Capital held at $31.0 million in Q1 2023 per MBIO's latest filing, from $31.0 million in the prior quarter.
• Across five years, Invested Capital topped out at $31.0 million in Q2 2022 and bottomed at $249000.0 in Q2 2021.
• Historically, Invested Capital has averaged $10.7 million across 5 years, with a median of $811000.0 in 2022.
• Annual changes were most pronounced in 2020 — Invested Capital slumped 96.88% — and 2022, when it jumped 12369.88%.
• Mustang Bio's Invested Capital stood at $1.2 million in 2019, then slumped by 60.8% to $490000.0 in 2020, then soared by 47.55% to $723000.0 in 2021, then jumped by 4194.61% to $31.0 million in 2022, then changed by 0.0% to $31.0 million in 2023.
• Business Quant data shows MBIO's Invested Capital at $31.0 million in Q1 2023, $31.0 million in Q4 2022, and $31.0 million in Q3 2022.